Calcium folinate pentahydrate
Acute on Chronic Liver Failure (ACLF)
European Foundation for Study of Chronic Liver FailureSmall moleculePhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 38/ 100
- Competitive Position
- 89/ 100
Competitive context
6 Active assets in the Acute on Chronic Liver Failure (ACLF) cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Epirubicin Genfit | Phase 2 | CCC |
CIS-DIAMMINEDICHLOROPLATINUM II European Foundation for Study of Chronic Liver Failure | Phase 2 | CCC |
Cyclophosphamide Genfit | Phase 2 | CCC |
Carboplatin Genfit | Phase 2 | CCC |
FLUOROURACILUM European Foundation for Study of Chronic Liver Failure | Phase 2 | CCC |
Pembrolizumab Genfit | Phase 2 | CCC |
Same molecule, other indications
Calcium folinate pentahydrate is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →